Jump to content
IndiaDivine.org

Our Deadly Diabetes Deception

Rate this topic


Guest guest

Recommended Posts

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

http://www.fourwinds10.com/news/06-health/B-disease/2004/06B-07-16-04-our-deadly

-diabetes-deception.html

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

 

Our Deadly Diabetes Deception

 

Greed and dishonest science have promoted a lucrative

worldwide

epidemic

of diabetes that honesty and good science can quickly

reverse by

naturally

restoring the body's blood-sugar control mechanism.

 

by Thomas Smith © 2004

 

PO Box 7685

 

Loveland, CO 80537 USA

 

http://www.Healingmatters.com

http://www.nexusmagazine.com/articles/DiabetesDeception.html

Introduction

 

If you are an American diabetic, your physician will

never tell you that

most cases of diabetes are curable. In fact, if you

even mention the

" cure " word around him, he will likely become upset

and irrational. His

medical school training only allows him to respond to

the word

" treatment " . For him, the " cure " word does not exist.

Diabetes, in its

modern epidemic form, is a curable disease and has

been for at least 40

years. In 2001, the most recent year for which US

figures are posted,

934,550 Americans died from out-of-control symptoms of

this disease.

 

Your physician will also never tell you that, at one

time, strokes, both

ischaemic and haemorrhagic, heart failure due to

neuropathy as well as

both ischaemic and haemorrhagic coronary events,

obesity, atherosclerosis,

elevated blood pressure, elevated cholesterol,

elevated triglycerides,

impotence, retinopathy, renal failure, liver failure,

polycystic ovary

syndrome, elevated blood sugar, systemic candida,

impaired carbohydrate

metabolism, poor wound healing, impaired fat

metabolism, peripheral

neuropathy as well as many more of today's disgraceful

epidemic disorders

were once well understood often to be but symptoms of

diabetes.

 

If you contract diabetes and depend upon orthodox

medical treatment,

sooner or later you will experience one or more of its

symptoms as the

disease rapidly worsens. It is now common practice to

refer to these

symptoms as if they were separable, independent

diseases with separate,

unrelated treatments provided by competing medical

specialists.

 

It is true that many of these symptoms can and

sometimes do result from

other causes; however, it is also true that this fact

has been used to

disguise the causative role of diabetes and to justify

expensive,

ineffective treatments for these symptoms.

 

Epidemic Type II diabetes is curable. By the time you

get to the end of

this article, you are going to know that. You're going

to know why it

isn't routinely being cured. And, you're going to know

how to cure it. You

are also probably going to be angry at what a handful

of greedy people

have surreptitiously done to the entire orthodox

medical community and to

its trusting patients.

 

The Diabetes Industry

 

Today's diabetes industry is a massive community that

has grown step by

step from its dubious origins in the early 20th

century. In the last 80

years it has become enormously successful at shutting

out competitive

voices that attempt to point out the fraud involved in

modern diabetes

treatment. It has matured into a religion. And, like

all religions, it

depends heavily upon the faith of the believer. So

successful has it

become that it verges on blasphemy to suggest that, in

most cases, the

kindly high priest with the stethoscope draped

prominently around his neck

is a charlatan and a fraud. In the large majority of

cases, he has never

cured a single case of diabetes in his entire medical

career.

 

The financial and political influence of this medical

community has almost

totally subverted the original intent of our

regulatory agencies. They

routinely approve death-dealing, ineffective drugs

with insufficient

testing. Former commissioner of the FDA, Dr Herbert

Ley, in testimony

before a US Senate hearing, commented: " People think

the FDA is protecting

them. It isn't. What the FDA is doing and what the

public thinks it's

doing are as different as night and day. "

 

The financial and political influence of this medical

community dominates

our entire medical insurance industry. Although this

is beginning to

change, in America it is still difficult to find

employer group medical

insurance to cover effective alternative medical

treatments. Orthodox

coverage is standard in all states. Alternative

medicine is not. For

example, there are only 1,400 licensed naturopaths in

11 states compared

to over 3.4 million orthodox licensees in 50 states.

Generally, only

approved treatments from licensed, credentialled

practitioners are

insurable. This, in effect, neatly creates a special

kind of money that

can only be spent within the orthodox medical and drug

industry. No other

industry in the world has been able to manage the

politics of convincing

people to accept so large a part of their pay in a

form that often does

not allow them to spend it as they see fit.

 

The financial and political influence of this medical

community completely

controls virtually every diabetes publication in the

country. Many

diabetes publications are subsidised by ads for

diabetes supplies. No

diabetes editor is going to allow the truth to be

printed in his magazine.

This is why the diabetic only pays about one-quarter

to one-third of the

cost of printing the magazine he depends upon for

accurate information.

The rest is subsidised by diabetes manufacturers with

a vested commercial

interest in preventing diabetics from curing their

diabetes. When looking

for a magazine that tells the truth about diabetes,

look first to see if

it is full of ads for diabetes supplies.

 

And then there are the various associations that

solicit annual donations

to find a cure for their proprietary disease. Every

year they promise that

a cure is just around the corner­just send more money!

Some of these very

same associations have been clearly implicated in

providing advice that

promotes the progress of diabetes in their trusting

supporters. For

example, for years they heavily promoted exchange

diets, which are in fact

scientifically worthless­as anyone who has ever tried

to use them quickly

finds out. They ridiculed the use of glycemic tables,

which are actually

very helpful to the diabetic. They promoted the use of

margarine as heart

healthy, long after it was well understood that

margarine causes diabetes

and promotes heart failure.

 

If people ever wake up to the cure for diabetes that

has been suppressed

for 40 years, these associations will soon be out of

business. But until

then, they nonetheless continue to need our support.

For 40 years, medical

research has consistently shown with increasing

clarity that diabetes is a

degenerative disease directly caused by an engineered

food supply that is

focused on profit instead of health. Although the

diligent can readily

glean this information from a wealth of medical

research literature, it is

generally otherwise unavailable. Certainly this

information has been, and

remains, largely unavailable in the medical schools

that train our retail

doctors.

 

Prominent among the causative agents in our modern

diabetes epidemic are

the engineered fats and oils that are sold in today's

supermarkets.The

first step to curing diabetes is to stop believing the

lie that the

disease is incurable. Diabetes History

 

In 1922, three Canadian Nobel Prize winners, Banting,

Best and Macleod,

were successful in saving the life of a

fourteen-year-old diabetic girl in

Toronto General Hospital with injectable insulin. Eli

Lilly was licensed

to manufacture this new wonder drug, and the medical

community basked in

the glory of a job well done.

 

It wasn't until 1933 that rumours about a new rogue

form of diabetes

surfaced. This was in a paper presented by Joslyn,

Dublin and Marks and

printed in the American Journal of Medical Sciences.

This paper, " Studies

on Diabetes Mellitus " , discussed the emergence of a

major epidemic of a

disease which looked very much like the diabetes of

the early 1920s, only

it did not respond to the wonder drug, insulin. Even

worse, sometimes

insulin treatment killed the patient.

 

This new disease became known as " insulin-resistant

diabetes " because it

had the elevated blood sugar symptom of diabetes but

responded poorly to

insulin therapy. Many physicians had considerable

success in treating this

disease through diet. A great deal was learned about

the relationship

between diet and diabetes in the 1930s and 1940s.

 

Diabetes, which had a per-capita incidence of 0.0028%

at the turn of the

century, had by 1933 zoomed 1,000% in the United

States to become a

disease seen by many doctors.This disease, under a

variety of aliases, was

destined to go on to wreck the health of over half the

American population

and incapacitate almost 20% by the 1990s.

 

In 1950, the medical community became able to perform

serum insulin

assays. These assays quickly revealed that this new

disease wasn't classic

diabetes; it was characterised by sufficient, often

excessive, blood

insulin levels. The problem was that the insulin was

ineffective; it did

not reduce blood sugar. But since the disease had been

known as diabetes

for almost 20 years, it was renamed Type II diabetes.

This was to

distinguish it from the earlier Type I diabetes,

caused by insufficient

insulin production by the pancreas. Had the dietary

insights of the

previous 20 years dominated the medical scene from

this point and into the

late 1960s, diabetes would have become widely

recognised as curable

instead of merely treatable. Instead, in 1950, a

search was launched for

another wonder drug to deal with the Type II diabetes

problem. Cure versus

Treatment

 

This new, ideal, wonder drug would be effective, like

insulin, in

remitting obvious adverse symptoms of the disease but

not effective in

curing the underlying disease. Thus it would be needed

continually for the

remaining life of the patient. It would have to be

patentable; that is, it

could not be a natural medication because these are

non-patentable. Like

insulin, it would have to be highly profitable to

manufacture and

distribute. Mandatory government approvals would be

required to stimulate

physicians to prescribe it as a prescription drug.

Testing required for

these approvals would have to be enormously expensive

to prevent other,

unapproved, medications from becoming competitive.

 

This is the origin of the classic medical protocol of

" treating the

symptoms " . By doing this, both the drug company and

the doctor could

prosper in business, and the patient, while not being

cured of his

disease, was sometimes temporarily relieved of some of

his symptoms.

 

Additionally, natural medications that actually cured

disease would have

to be suppressed. The more effective they were, the

more they would need

to be suppressed and their proponents jailed as

quacks. After all, it

wouldn't do to have some cheap, effective, natural

medication cure disease

in a capital-intensive monopoly market specifically

designed to treat

symptoms without curing disease. Often the natural

substance really did

cure disease. This is why the force of law has been

and is being used to

drive the natural, often superior, medicines from the

marketplace, to

remove the " cure " word from the medical vocabulary and

to undermine

totally the very concept of a free marketplace in the

medical business.

 

Now it is clear why the " cure " word is so vigorously

suppressed by law.

The FDA has extensive Orwellian regulations that

prohibit the use of the

" cure " word to describe any competing medicine or

natural substance. It is

precisely because many natural substances do actually

both cure and

prevent disease that this word has become so

frightening to the drug and

orthodox medical community. The Commercial Value of

Symptoms

 

After the drug development policy was redesigned to

focus on ameliorating

symptoms rather than curing disease, it became

necessary to reinvent the

way drugs were marketed. This was done in 1949 in the

midst of a major

epidemic of insulin-resistant diabetes.

 

So, in 1949, the US medical community reclassified the

symptoms of

diabetes along with many other disease symptoms into

diseases in their own

right. With this reclassification as the new basis for

diagnosis,

competing medical speciality groups quickly seized

upon related groups of

symptoms as their own proprietary symptoms set.

 

Thus the heart specialist, endocrinologist, allergist,

kidney specialist

and many others started to treat the symptoms for

which they felt

responsible. As the underlying cause of the disease

was widely ignored,

all focus on actually curing anything was completely

lost. Heart failure,

for example, which had previously been understood

often to be but a

symptom of diabetes, now became a disease not directly

connected to

diabetes. It became fashionable to think that diabetes

" increased

cardiovascular risk " . The causal role of a failed

blood-sugar control

system in heart failure became obscured.

 

Consistent with the new medical paradigm, none of the

treatments offered

by the heart specialist actually cures, or is even

intended to cure, their

proprietary disease. For example, the three-year

survival rate for bypass

surgery is almost exactly the same as if no surgery

was undertaken.

 

Today, over half of the people in America suffer from

one or more symptoms

of this disease. In its beginnings, it became well

known to physicians as

Type II diabetes, insulin-resistant diabetes, insulin

resistance,

adult-onset diabetes or, more rarely,

hyperinsulinaemia. According to the

American Heart Association, almost 50% of Americans

suffer from one or

more symptoms of this disease. One third of the US

population is morbidly

obese; half of the population is overweight. Type II

diabetes, also called

adult-onset diabetes, now appears routinely in

six-year-old children.

 

Many degenerative diseases can be traced to a massive

failure of the

endocrine system. This was well known to the

physicians of the 1930s as

insulin-resistant diabetes. This basic underlying

disorder is known to be

a derangement of the blood-sugar control system by

badly engineered fats

and oils. It is exacerbated and complicated by the

widespread lack of

other essential nutrition that the body needs to cope

with the metabolic

consequences of these poisons. All fats and oils are

not equal. Some are

healthy and beneficial; many, commonly available in

the supermarket, are

poisonous. The health distinction is not between

saturated and

unsaturated, as the fats and oils industry would have

us believe. Many

saturated oils and fats are highly beneficial; many

unsaturated oils are

highly poisonous. The important health distinction is

between natural and

engineered.

 

There exists great dishonesty in advertising in the

fats and oils

industry. It is aimed at creating a market for cheap

junk oils such as

soy, cottonseed and rapeseed oils. With an informed

and aware public,

these oils would have no market at all, and the

USA­indeed, the

world­would have far fewer cases of diabetes.

 

Epidemiological Lifestyle Link

 

As early as 1901, efforts had been made to manufacture

and sell food

products by the use of automated factory machinery

because of the immense

profits that were possible. Most of the early efforts

failed because

people were inherently suspicious of food that wasn't

farm fresh and

because the technology was poor. As long as people

were prosperous,

suspicious food products made little headway. Crisco,

the artificial

shortening, was once given away free in 21 & #8260;2 lb

cans in an

unsuccessful effort to influence American housewives

to trust and buy the

product in preference to lard.

 

Margarine was introduced and was bitterly opposed by

the dairy states in

the USA. With the advent of the Depression of the

1930s, margarine, Crisco

and a host of other refined and hydrogenated products

began to make

significant penetration into the food markets of

America. Support for

dairy opposition to margarine faded during World War

II because there

wasn't enough butter for the needs of both the

civilian population and the

military. At this point, the dairy industry, having

lost much support,

simply accepted a diluted market share and

concentrated on supplying the

military.

 

Flax oils and fish oils, which were common in the

stores and considered

dietary staples before the American population became

diseased, have

disappeared from the shelf. The last supplier of flax

oil to the major

distribution chains was Archer Daniels Midland, and it

stopped producing

and supplying the product in 1950.

 

More recently, one of the most important of the

remaining, genuinely

beneficial, fats was subjected to a massive media

disinformation campaign

that portrayed it as a saturated fat that causes heart

failure. As a

result, it has virtually disappeared from the

supermarket shelves. Thus

was coconut oil removed from the food chain and

replaced with soy oil,

cottonseed oil and rapeseed oil. Our parents and

grandparents would never

have swapped a fine, healthy oil like coconut oil for

these cheap, junk

oils. It was shortly after this successful media blitz

that the US

populace lost its war on fat. For many years, coconut

oil had been our

most effective dietary weight-control agent.

 

The history of the engineered adulteration of our

once-clean food supply

exactly parallels the rise of the epidemic of diabetes

and

hyperinsulinaemia now sweeping the United States as

well as much of the

rest of the world. The second step to a cure for this

disease epidemic is

to stop believing the lie that our food supply is safe

and nutritious. The

Nature of the Disease

 

Diabetes is classically diagnosed as a failure of the

body to metabolise

carbohydrates properly. Its defining symptom is a high

blood-glucose

level. Type I diabetes results from insufficient

insulin production by the

pancreas. Type II diabetes results from ineffective

insulin. In both

types, the blood-glucose level remains elevated.

Neither insufficient

insulin nor ineffective insulin can limit

post-prandial (after-eating)

blood sugar to the normal range. In established cases

of Type II diabetes,

these elevated blood sugar levels are often preceded

and accompanied by

chronically elevated insulin levels and by serious

distortions of other

endocrine hormonal markers.

 

The ineffective insulin is no different from effective

insulin. Its

ineffectiveness lies in the failure of the cell

population to respond to

it. It is not the result of any biochemical defect in

the insulin itself.

Therefore, it is appropriate to note that this is a

disease that affects

almost every cell in the 70 trillion or so cells of

the body. All of these

cells are dependent upon the food that we eat for the

raw materials they

need for self repair and maintenance.

 

The classification of diabetes as a failure to

metabolise carbohydrates is

a traditional classification that originated in the

early 19th century

when little was known about metabolic diseases or

processes. Today, with

our increased knowledge of these processes, it would

appear quite

appropriate to define Type II diabetes more

fundamentally as a failure of

the body to metabolise fats and oils properly. This

failure results in a

loss of effectiveness of insulin and in the consequent

failure to

metabolise carbohydrates. Unfortunately, much medical

insight into this

matter, except at the research level, remains hampered

by its 19th-century

legacy.

 

Thus Type II diabetes and its early hyperinsulinaemic

symptoms are

whole-body symptoms of this basic cellular failure to

metabolise glucose

properly. Each cell of the body, for reasons which are

becoming clearer,

finds itself unable to transport glucose from the

bloodstream to its

interior. The glucose then remains in the bloodstream,

or is stored as

body fat or as glycogen, or is otherwise disposed of

in urine.

 

It appears that when insulin binds to a cell membrane

receptor, it

initiates a complex cascade of biochemical reactions

inside the cell. This

causes a class of glucose transporters known as GLUT4

molecules to leave

their parking area inside the cell and travel to the

inside surface of the

plasma cell membrane.

 

When in the membrane, they migrate to special areas of

the membrane called

caveolae areas. There, by another series of

biochemical reactions, they

identify and hook up with glucose molecules and

transport them into the

interior of the cell by a process called endocytosis.

Within the cell's

interior, this glucose is then burned as fuel by the

mitochondria to

produce energy to power cellular activity. Thus these

GLUT4 transporters

lower glucose in the bloodstream by transporting it

out of the bloodstream

into all the cells of the body.

 

Many of the molecules involved in these glucose- and

insulin-mediated

pathways are lipids; that is, they are fatty acids. A

healthy plasma cell

membrane, now known to be an active player in the

glucose scenario,

contains a complement of cis-type w=3 unsaturated

fatty acids. This makes

the membrane relatively fluid and slippery. When these

cis- fatty acids

are chronically unavailable because of our diet,

trans- fatty acids and

short- and medium-chain saturated fatty acids are

substituted in the cell

membrane. These substitutions make the cellular

membrane stiffer and more

sticky, and inhibit the glucose transport mechanism.

 

Thus, in the absence of sufficient cis omega 3 fatty

acids in our diet,

these fatty acid substitutions take place, the

mobility of the GLUT4

transporters is diminished, the interior biochemistry

of the cell is

changed and glucose remains elevated in the

bloodstream. Elsewhere in the

body, the pancreas secretes excess insulin, the liver

manufactures fat

from the excess sugar, the adipose cells store excess

fat, the body goes

into a high urinary mode, insufficient cellular energy

is available for

bodily activity and the entire endocrine system

becomes distorted.

Eventually, pancreatic failure occurs, body weight

plummets and a diabetic

crisis is precipitated.

 

Although there remains much work to be done to

elucidate fully all of the

steps in all of these pathways, this clearly marks the

beginning of a

biochemical explanation for the known epidemiological

relationship between

cheap, engineered dietary fats and oils and the onset

of Type II diabetes.

Orthodox Medical Treatment

 

After the diagnosis of diabetes, modern orthodox

medical treatment

consists of either oral hypoglycaemic agents or

insulin. • Oral

hypoglycaemic agents

 

In 1955, oral hypoglycaemic drugs were introduced.

Currently available

oral hypoglycaemic agents fall into five

classifications according to

their biophysical mode of action. These classes are:

biguanides;

glucosidase inhibitors; meglitinides; sulphonylureas;

and

thiazolidinediones. The biguanides lower blood sugar

in three ways. They

inhibit the normal release by the liver of its glucose

stores, they

interfere with intestinal absorption of glucose from

ingested

carbohydrates, and they are said to increase

peripheral uptake of glucose.

 

The glucosidase inhibitors are designed to inhibit the

amylase enzymes

produced by the pancreas and which are essential to

the digestion of

carbohydrates. The theory is that if the digestion of

carbohydrates is

inhibited, the blood sugar level cannot be elevated.

The meglitinides are

designed to stimulate the pancreas to produce insulin

in a patient that

likely already has an elevated level of insulin in

their bloodstream. Only

rarely does the doctor even measure the insulin level.

Indeed, these drugs

are frequently prescribed without any knowledge of the

pre-existing

insulin level. The fact that an elevated insulin level

is almost as

damaging as an elevated glucose level is widely

ignored.

 

The sulphonylureas are another pancreatic stimulant

class designed to

stimulate the production of insulin. Serum insulin

determinations are

rarely made by the doctor before he prescribes these

drugs. They are often

prescribed for Type II diabetics, many of whom already

have elevated

ineffective insulin. These drugs are notorious for

causing hypoglycaemia

as a side effect.

 

The thiazolidinediones are famous for causing liver

cancer. One of them,

Rezulin, was approved in the USA through devious

political infighting, but

failed to get approval in the UK because it was known

to cause liver

cancer. The doctor who had responsibility to approve

it at the FDA refused

to do so. It was only after he was replaced by a more

compliant official

that Rezulin gained approval by the FDA. It went on to

kill well over 100

diabetes patients and cripple many others before the

fight to get it off

the market was finally won. Rezulin was designed to

stimulate the uptake

of glucose from the bloodstream by the peripheral

cells and to inhibit the

normal secretion of glucose by the liver. The politics

of why this drug

ever came onto market, and then remained in the market

for such an

unexplainable length of time with regulatory agency

approval, is not

clear. As of April 2000, lawsuits commenced to clarify

this situation. •

Insulin

 

Today, insulin is prescribed for both the Type I and

Type II diabetics.

Injectable insulin substitutes for the insulin that

the body no longer

produces. Of course, this treatment, while necessary

for preserving the

life of the Type I diabetic, is highly questionable

when applied to the

Type II diabetic. It is important to note that neither

insulin nor any of

these oral hypoglycaemic agents exerts any curative

action whatsoever on

any type of diabetes. None of these medical strategies

is designed to

normalise the cellular uptake of glucose by the cells

that need it to

power their activity.

 

The prognosis with this orthodox treatment is

increasing disability and

early death from heart or kidney failure or the

failure of some other

vital organ. Alternative Medical Treatment

 

The third step to a cure for this disease is to become

informed and to

apply an alternative methodology that is soundly based

upon good science.

Effective alternative treatment that directly leads to

a cure is available

today for some Type I and for many Type II diabetics.

About 5% of the

diabetic population suffers from Type I diabetes;

about 95% has Type II

diabetes. Gestational diabetes is simply ordinary

diabetes contracted by a

woman who is pregnant.

 

For the Type I diabetic, an alternative methodology

for the treatment of

Type I diabetes is now available. It was developed in

modern hospitals in

Madras, India, and subjected to rigorous double-blind

studies to prove its

efficacy. It operates to restore normal pancreatic

beta cell function so

that the pancreas can again produce insulin as it

should. This approach

apparently was capable of curing Type I diabetes in

over 60% of the

patients on whom it was tested. The major complication

lies in whether the

antigens that originally led to the autoimmune

destruction of these beta

cells have disappeared from or remain in the body. If

they remain, a cure

is less likely; if they have disappeared, the cure is

more likely. For

reasons already discussed, this methodology is not

likely to appear in the

United States any time soon, and certainly not in the

American orthodox

medical community.

 

The goal of any effective alternative program is to

repair and restore the

body's own blood-sugar control mechanism. It is the

malfunctioning of this

mechanism that, over time, directly causes all of the

many debilitating

symptoms that make orthodox treatment so financially

rewarding for the

diabetes industry. For Type II diabetes, the steps in

the program are: •

Repair the faulty blood sugar control system. This is

done simply by

substituting clean, healthy, beneficial fats and oils

in the diet for the

pristine-looking but toxic trans-isomer mix found in

attractive plastic

containers on supermarket shelves. Consume only flax

oil, fish oil and

occasionally cod liver oil until blood sugar starts to

stabilise. Then add

back healthy oils such as butter, coconut oil, olive

oil and clean animal

fat. Read labels; refuse to consume cheap junk oils

when they appear in

processed food or on restaurant menus. Diabetics are

chronically short of

minerals; they need to add a good-quality,

broad-spectrum mineral

supplement to the diet. • Control blood sugar manually

during the recovery

cycle. Under medical supervision, gradually

discontinue all oral

hypoglycaemic agents along with any additional drugs

given to counteract

their side effects. Develop natural blood-sugar

control by the use of

glycaemic tables, by consuming frequent small meals

(including fibre-rich

foods), by regular post-prandial exercise, and by the

complete avoidance

of all sugars along with the judicious use of only

non-toxic sweeteners.

Avoid alcohol until blood sugar stabilises in the

normal range. Keep score

by using a pinprick-type glucose meter. Keep track of

everything you do

with a medical diary. • Restore a proper balance of

healthy fats and oils

when the blood sugar controller again works.

Permanently remove from the

diet all cheap, toxic, junk fats and oils as well as

the processed and

restaurant foods that contain them. When the blood

sugar controller again

starts to work correctly, gradually introduce

additional healthy foods to

the diet. Test the effect of these added foods by

monitoring blood sugar

levels with the pinprick-type blood sugar monitor. Be

sure to include the

results of these tests in your diary also. • Continue

the program until

normal insulin values are also restored after blood

sugar levels begin to

stabilise in the normal region. Once blood sugar

levels fall into the

normal range, the pancreas will gradually stop

overproducing insulin. This

process will typically take a little longer and can be

tested by having

your physician send a sample of your blood to a lab

for a serum insulin

determination. A good idea is to wait a couple of

months after blood sugar

control is restored and then have your physician check

your insulin level.

It's nice to have blood sugar in the normal range;

it's even nicer to have

this accomplished without excess insulin in the

bloodstream. • Separately

repair the collateral damage done by the disease.

Vascular problems caused

by a chronically elevated glucose level will normally

reverse themselves

without conscious effort. The effects of retinopathy

and of peripheral

neuropathy, for example, will usually self repair.

However, when the fine

capillaries in the basement membranes of the kidneys

begin to leak due to

chronic high blood glucose, the kidneys compensate by

laying down scar

tissue to prevent the leakage. This scar tissue

remains even after the

diabetes is cured, and is the reason why the kidney

damage is not believed

to self repair. A word of warning… When retinopathy

develops, there may be

a temptation to have the damage repaired by laser

surgery. This laser

technique stops the retinal bleeding by creating scar

tissue where the

leaks have developed. This scar tissue will prevent

normal healing of the

fine capillaries in the eye when the diabetes is

reversed. By reversing

the diabetes instead of opting for laser surgery,

there is an excellent

chance that the eye will heal completely. However, if

laser surgery is

done, this healing will always be complicated by the

scar tissue left by

the laser. The arterial and vascular damage done by

years of elevated

sugar and insulin and by the proliferation of systemic

candida will slowly

reverse due to improved diet. However, it takes many

years to clean out

the arteries by this form of oral chelation. Arterial

damage can be

reversed much more quickly by using intravenous

chelation therapy. What

would normally take many years through diet alone can

often be done in six

months with intravenous therapy. This is reputed to be

effective over 80%

of the time. For obvious reasons, don't expect your

doctor to approve of

this, particularly if he's a heart specialist.

Recovery Time

 

The prognosis is usually swift recovery from the

disease and restoration

of normal health and energy levels in a few months to

a year or more. The

length of time that it takes to effect a cure depends

upon how long the

disease was allowed to develop. For those who work

quickly to reverse the

disease after early discovery, the time is usually a

few months or less.

For those who have had the disease for many years,

this recovery time may

lengthen to a year or more. Thus, there is good reason

to get busy

reversing this disease as soon as it becomes clearly

identified.

 

By the time you get to this point in this article, and

if we've done a

good job of explaining our diabetes epidemic, you

should know what causes

it, what orthodox medical treatment is all about, and

why diabetes has

become a national and international disgrace. Of even

greater importance,

you have become acquainted with a self-help program

that has demonstrated

great potential to actually cure this disease. & #8734;

About the Author:

 

Thomas Smith is a reluctant medical investigator,

having been forced into

curing his own diabetes because it was obvious that

his doctor would not

or could not cure it. He has published the results of

his successful

diabetes investigation in his self-help manual,

Insulin: Our Silent

Killer, written for the layperson but also widely

valued by the medical

practitioner. This manual details the steps required

to reverse Type II

diabetes and references the work being done with Type

I diabetes. The book

may be purchased from the author at PO Box 7685,

Loveland, Colorado 80537,

USA (North American residents send $US25.00; overseas

residents should

contact the author for payment and shipping

instructions).

 

Thomas Smith has also posted a great deal of useful

information about

diabetes on his website, http://www.Healingmatters.

com. He can be

contacted by telephone at +1 (970) 669 9176 and by

email at

valley. Endnotes:

 

1. National Center for Health Statistics, " Fast

Stats " , Deaths/Mortality

Preliminary 2001 data

 

2. Dr Herbert Ley, in response to a question from

Senator Edward Long

about the FDA during US Senate hearings in 1965

 

3. Eisenberg, David M., MD, " Credentialing

complementary and alternative

medical providers " , Annals of Internal Medicine

137(12):968 (December 17,

2002)

 

4. American Diabetes Association and the American

Dietetic Association,

The Official Pocket Guide to Diabetic Exchanges,

McGraw-Hill/Contemporary

Distributed Products, newly updated March 1, 1998

 

5. American Heart Association, " How Do I Follow a

Healthy Diet? " , American

Heart Association

 

National Center (7272 Greenville Avenue, Dallas, Texas

75231-4596, USA),

http://www.americanheart.org

 

6. Brown., J.A.C., Pears Medical Encyclopedia

Illustrated, 1971, p. 250

 

7. Joslyn, E.P., Dublin, L.I., Marks, H.H., " Studies

on Diabetes

Mellitus " , American Journal of Medical Sciences

186:753-773 (1933)

 

8. " Diabetes Mellitus " , Encyclopedia Americana,

Library Edition, vol. 9,

1966, pp. 54-56

 

9. American Heart Association, " Stroke (Brain

Attack) " , August 28, 1998,

http://www.amhrt.org/ScientificHStats98/05stroke.html;

 

American Heart Association, " Cardiovascular Disease

Statistics " , August

28, 1998,

http://www.amhrt.org/Heart_and_Stroke_A_Z_Guide/cvds.html;

 

" Statistics related to overweight and obesity " ,

 

http://niddk.nih.gov/health/nutrit/pubs/statobes.htm;

 

http://www.winltdusa.com/about/infocenter/

 

healthnews/articles/obesestats.htm

 

10. " Diabetes Mellitus " , Encyclopedia Americana,

ibid., pp. 54-55

 

11. The Veterans Administration Coronary Artery Bypass

Co-operative Study

Group, " Eleven-year survival in the Veterans

Administration randomized

trial of coronary bypass surgery for stable angina " ,

New Eng. J. Med.

311:1333-1339 (1984); Coronary Artery Surgery Study

(CASS), " A randomized

trial of coronary artery bypass surgery: quality of

life in patients

randomly assigned to treatment groups " , Circulation

68(5):951-960 (1983)

 

12. Trager, J., The Food Chronology, Henry Holt &

Company, New York, 1995

(items listed by date)

 

13. " Margarine " , Encyclopedia Americana, Library

Edition, vol. 9, 1966,

pp. 279-280

 

14. Fallon, S., Connolly, P., Enig, M.C., Nourishing

Traditions, Promotion

Publishing, 1995;

 

Enig, M.C., " Coconut: In Support of Good Health in the

21st Century " ,

http://www.livecoconutoil.com/maryenig.htm

 

15. Houssay, Bernardo, A., MD, et al., Human

Physiology, McGraw-Hill Book

Company, 1955, pp. 400-421

 

16. Gustavson, J., et al., " Insulin-stimulated glucose

uptake involves the

transition of glucose transporters to a caveolae-rich

fraction within the

plasma cell membrane: implications for type II

diabetes " , Mol. Med.

2(3):367-372 (May 1996)

 

17. Ganong, William F., MD, Review of Medical

Physiology, 19th edition,

1999, p. 9, pp. 26-33

 

18. Pan, D.A. et al., " Skeletal muscle membrane lipid

composition is

related to adiposity and insulin action " , J. Clin.

Invest. 96(6):2802-2808

(December 1995)

 

19. Physicians' Desk Reference, 53rd edition, 1999

 

20. Smith, Thomas, Insulin: Our Silent Killer, Thomas

Smith, Loveland,

Colorado, revised 2nd

 

edition, July 2000, p. 20

 

21. Law Offices of Charles H. Johnson & Associates

(telephone 1 800 535

5727, toll free in North America)

 

22. American Heart Association, " Diabetes Mellitus

Statistics " ,

http://www.amhrt.org

 

23. Shanmugasundaram, E.R.B. et al. (Dr Ambedkar

Institute of Diabetes,

Kilpauk Medical College Hospital, Madras, India),

" Possible regeneration

of the Islets of Langerhans in Streptozotocin-diabetic

rats given Gymnema

sylvestre leaf extract " , J. Ethnopharmacology

30:265-279 (1990);

 

Shanmugasundaram, E.R.B. et al., " Use of Gemnema

sylvestre leaf extract in

the control of blood glucose in insulin-dependent

diabetes mellitus " , J.

Ethnopharmacology 30:281-294 (1990)

 

24. Smith, ibid., pp. 97-123

 

25. Many popular artificial sweeteners on sale in the

supermarket are

extremely poisonous and dangerous to the diabetic;

indeed, many of them

are worse than the sugar the diabetic is trying to

avoid; see, for

example, Smith, ibid., pp. 53-58.

 

26. Walker, Morton, MD, and Shah, Hitendra, MD,

Chelation Therapy, Keats

Publishing, Inc., New Canaan, Connecticut, 1997, ISBN

0-87983-730-6

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...